Peter Lamb Exelixis, Inc. (EXEL) insider trading activity

Peter Lamb is EVP, Scientific Strategy & CSO of EXELIXIS, INC.. Currently has a direct ownership of 410,958 shares of EXEL, which is worth approximately $14 Million. The most recent transaction as insider was on Jun 17, 2021, when has been sold 60,000 shares (Common Stock) at a price of $22.18 per share, resulting in proceeds of $1,330,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 411K

0% 3M change

0% 12M change

Total Value Held $14 Million

Peter Lamb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 17 2021	SELL Open market or private sale	$1,330,800 $22.18 p/Share	60,000 Reduced 13.35%	389,467 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$114,000 $1.9 p/Share	60,000 Added 11.78%	449,467 Common Stock
Apr 01 2021	SELL Open market or private sale	$1,377,600 $22.96 p/Share	60,000 Reduced 13.35%	389,467 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$102,000 $1.7 p/Share	60,000 Added 11.78%	449,467 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	49,395 Added 11.26%	389,467 Common Stock
Mar 01 2021	SELL Open market or private sale	$1,437,150 $22.11 p/Share	65,000 Reduced 16.05%	340,072 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$110,500 $1.7 p/Share	65,000 Added 13.83%	405,072 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$81,461 $21.91 p/Share	3,718 Reduced 1.08%	340,072 Common Stock
Feb 03 2021	SELL Payment of exercise price or tax liability	$451,132 $22.56 p/Share	19,997 Reduced 5.5%	343,790 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	80,663 Added 18.15%	363,787 Common Stock
Feb 01 2021	SELL Open market or private sale	$1,435,200 $22.08 p/Share	65,000 Reduced 18.67%	283,124 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$110,500 $1.7 p/Share	65,000 Added 15.73%	348,124 Common Stock
Jan 04 2021	SELL Open market or private sale	$1,320,800 $20.32 p/Share	65,000 Reduced 18.67%	283,124 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$110,500 $1.7 p/Share	65,000 Added 15.73%	348,124 Common Stock
Dec 18 2020	SELL Open market or private sale	$1,300,650 $20.01 p/Share	65,000 Reduced 18.67%	283,124 Common Stock
Dec 18 2020	BUY Exercise of conversion of derivative security	$110,500 $1.7 p/Share	65,000 Added 15.73%	348,124 Common Stock
Nov 15 2020	SELL Payment of exercise price or tax liability	$228,030 $20.16 p/Share	11,311 Reduced 3.84%	283,124 Common Stock
Oct 22 2020	SELL Payment of exercise price or tax liability	$1,155,349 $21.79 p/Share	53,022 Reduced 15.26%	294,435 Common Stock
Oct 22 2020	BUY Grant, award, or other acquisition	-	213,879 Added 38.1%	347,457 Common Stock

Peter Lamb

EVP, Scientific Strategy & CSO

Alameda, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Value

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL

Account